LIBERATE-D (2026) — Trial Summary

LIBERATE-D (2026): Multicenter, unblinded, randomized superiority trial at 4 U.S. sites comparing a conservative (indication-based) intermittent dialysis strategy with conventional thrice-weekly dialysis in hemodynamically stable adults with dialysis-requiring AKI (AKI-D) already on KRT (NCT04218370

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.